Session Type
Meeting
Search Results for withdrawal
Abstract Number: 156
SHM Converge 2023
Background: Although alcohol withdrawal (AW) is common in hospitalized patients, few studies describe contemporary alcohol withdrawal management in hospitalized settings or compare practices to recent guidelines published by the American Society of Addiction Medicine (ASAM). We sought to describe patient characteristics and determine factors associated with complicated withdrawal and treatment duration in hospitalized patients with […]
Abstract Number: 173
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Approximately 1.6 million men and 800,000 women in the US are alcohol dependent and have an alcohol-use disorder. Half will experience withdrawal symptoms after decreased alcohol consumption. Complications including seizures and delirium tremens occur in 3-5% . Benzodiazepines are the gold standard for treatment of alcohol withdrawal but choice of drug regimens varies widely. […]
Abstract Number: 240
Hospital Medicine 2020, Virtual Competition
Background: Severe alcohol withdrawal and delirium tremens (DTs) are challenging therapeutic dilemmas. To prevent complications and death, management requires close monitoring and intensive treatment, frequently in an ICU. Benzodiazepines are first line therapeutic agents, but optimal use and dosing has been limited, due to a lack of randomized double-blind trials. In lower acuity patients admitted […]
Abstract Number: 243
SHM Converge 2023
Background: Phenobarbital (PB) has important pharmacological advantages over benzodiazepines (BZDs) for treatment of alcohol withdrawal syndrome (AWS). The American Society of Addiction Medicine recommends PB monotherapy as an alternative to BZDs for prophylaxis or treatment of AWS by providers experienced with its use. Few studies have described the use of PB for AWS outside of […]
Abstract Number: 277
SHM Converge 2021
Background: Alcohol use disorder (AUD) has a lifetime prevalence of 29% in the United States and prevalence is higher among military veterans. Discontinuation of alcohol use in patients with AUD presents a risk for alcohol withdrawal syndrome (AWS). A recent retrospective analysis of Veterans Health Administration (VHA) data estimated AWS occurred in 5.8% of inpatient […]
Abstract Number: 281
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Health care proxies (HCP), decision-making surrogates and involved family members often struggle with indecision when offered the option of went withdrawal (VW) for a patient who is intubated. A VW is a procedure offered when an intubated patient fails to demonstrate meaningful recovery or the patient is not likely to survive given the extent […]
Abstract Number: 301
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Cardiac telemetry is frequently overused in the hospital. Our institution requires telemetry while patients are on the Clinical Institute Withdrawal Assessment (CIWA) protocol, regardless of the presence or severity of alcohol withdrawal (AW). Telemetry use in this population has not been studied or incorporated into guidelines, however some patients may need monitoring for co-existing indications. […]
Abstract Number: 358
SHM Converge 2023
Background: The incidence of Opioid Use Disorder (OUD) is rising around the world with nearly 27 million people living with OUD globally and over 100,000 opioid overdose deaths each year. The Society of Hospital Medicine recently released a consensus statement for management of patients with OUD admitted to the hospital. This statement included recommendations for […]
Abstract Number: 368
SHM Converge 2023
Background: Approximately 5% of patients hospitalized at our institution develop clinically significant alcohol withdrawal syndrome (AWS). Inpatients who develop AWS may experience seizures, delirium, ICU transfer and prolonged length of stay. While the mortality of AWS, mostly related to delirium tremens, has decreased over time, severe alcohol withdrawal is still associated with a mortality of […]
Abstract Number: 500
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 76-year-old man with seropositive RA treated with MTX 15-20mg weekly for at least four years presented to the hospital with worsening fatigue, generalized weakness, poor appetite, and dyspnea. Contrast-enhanced computed tomography of chest abdomen and pelvis (CT CAP) demonstrated numerous pulmonary nodules, centrally hypodense left retroperitoneal soft tissue masses which may represent […]